31.77
-0.03(-0.09%)
Currency In USD
| Previous Close | 31.8 |
| Open | 31.97 |
| Day High | 32.3 |
| Day Low | 31.46 |
| 52-Week High | 45.3 |
| 52-Week Low | 27.34 |
| Volume | 359,787 |
| Average Volume | 1.2M |
| Market Cap | 2.92B |
| PE | -17.85 |
| EPS | -1.78 |
| Moving Average 50 Days | 33.04 |
| Moving Average 200 Days | 34.76 |
| Change | -0.03 |
If you invested $1000 in Legend Biotech Corporation (LEGN) since IPO date, it would be worth $858.65 as of November 10, 2025 at a share price of $31.77. Whereas If you bought $1000 worth of Legend Biotech Corporation (LEGN) shares 3 years ago, it would be worth $610.96 as of November 10, 2025 at a share price of $31.77.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Legend Biotech to Host Investor Conference Call on Third Quarter 2025 Results
GlobeNewswire Inc.
Oct 29, 2025 12:00 PM GMT
SOMERSET, N.J., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, will host a conference call for investors at 8:00 am ET on Wednesday, November 12, 2025, to review third
Legend Biotech to Participate in the Morgan Stanley Global Healthcare Conference
GlobeNewswire Inc.
Aug 26, 2025 12:00 PM GMT
SOMERSET, N.J., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today announced that Ying Huang, Ph.D., the company’s Chief Executive Officer, will participate in a fire
Legend Biotech Appoints Carlos Santos as Chief Financial Officer
GlobeNewswire Inc.
Aug 18, 2025 12:00 PM GMT
SOMERSET, N.J., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today announced the appointment of Carlos Santos as the Company’s Chief Financial Officer, effective imme